nodes	percent_of_prediction	percent_of_DWPC	metapath
Acebutolol—ABCB1—melanoma	0.539	1	CbGaD
Acebutolol—CYP2D6—Vemurafenib—melanoma	0.0715	0.483	CbGbCtD
Acebutolol—ABCB1—Dactinomycin—melanoma	0.0504	0.341	CbGbCtD
Acebutolol—ABCB1—Docetaxel—melanoma	0.026	0.176	CbGbCtD
Acebutolol—Amnesia—Carmustine—melanoma	0.00149	0.00622	CcSEcCtD
Acebutolol—Hot flush—Temozolomide—melanoma	0.00145	0.00604	CcSEcCtD
Acebutolol—Amnesia—Temozolomide—melanoma	0.00144	0.00601	CcSEcCtD
Acebutolol—Menopausal symptoms—Temozolomide—melanoma	0.00143	0.00598	CcSEcCtD
Acebutolol—Dermatitis exfoliative—Temozolomide—melanoma	0.00143	0.00598	CcSEcCtD
Acebutolol—Cough—Vemurafenib—melanoma	0.00139	0.00581	CcSEcCtD
Acebutolol—Bronchospasm—Bleomycin—melanoma	0.00136	0.00569	CcSEcCtD
Acebutolol—Oropharyngeal pain—Docetaxel—melanoma	0.00136	0.00569	CcSEcCtD
Acebutolol—Arthralgia—Vemurafenib—melanoma	0.00136	0.00566	CcSEcCtD
Acebutolol—Myalgia—Vemurafenib—melanoma	0.00136	0.00566	CcSEcCtD
Acebutolol—Unspecified disorder of skin and subcutaneous tissue—Vemurafenib—melanoma	0.00135	0.00562	CcSEcCtD
Acebutolol—Aspartate aminotransferase increased—Dactinomycin—melanoma	0.00135	0.00562	CcSEcCtD
Acebutolol—Affect lability—Temozolomide—melanoma	0.00133	0.00556	CcSEcCtD
Acebutolol—Blood bilirubin increased—Docetaxel—melanoma	0.00131	0.00547	CcSEcCtD
Acebutolol—Mood swings—Temozolomide—melanoma	0.00128	0.00535	CcSEcCtD
Acebutolol—Nervous system disorder—Vemurafenib—melanoma	0.00128	0.00532	CcSEcCtD
Acebutolol—Skin disorder—Vemurafenib—melanoma	0.00126	0.00527	CcSEcCtD
Acebutolol—Pneumonia—Bleomycin—melanoma	0.00124	0.00519	CcSEcCtD
Acebutolol—Aspartate aminotransferase increased—Temozolomide—melanoma	0.00122	0.00508	CcSEcCtD
Acebutolol—Hypotension—Vemurafenib—melanoma	0.00122	0.00507	CcSEcCtD
Acebutolol—Musculoskeletal discomfort—Vemurafenib—melanoma	0.00119	0.00495	CcSEcCtD
Acebutolol—Pneumonia—Dactinomycin—melanoma	0.00116	0.00484	CcSEcCtD
Acebutolol—Decreased appetite—Vemurafenib—melanoma	0.00113	0.00472	CcSEcCtD
Acebutolol—Gastrointestinal disorder—Vemurafenib—melanoma	0.00112	0.00469	CcSEcCtD
Acebutolol—Fatigue—Vemurafenib—melanoma	0.00112	0.00468	CcSEcCtD
Acebutolol—Constipation—Vemurafenib—melanoma	0.00111	0.00464	CcSEcCtD
Acebutolol—Lightheadedness—Docetaxel—melanoma	0.00111	0.00463	CcSEcCtD
Acebutolol—Hypoaesthesia—Bleomycin—melanoma	0.0011	0.00461	CcSEcCtD
Acebutolol—Dysuria—Temozolomide—melanoma	0.00109	0.00456	CcSEcCtD
Acebutolol—Pneumonia—Carmustine—melanoma	0.00109	0.00453	CcSEcCtD
Acebutolol—Erectile dysfunction—Temozolomide—melanoma	0.00108	0.00449	CcSEcCtD
Acebutolol—Depression—Carmustine—melanoma	0.00108	0.00449	CcSEcCtD
Acebutolol—Agranulocytosis—Dactinomycin—melanoma	0.00108	0.00449	CcSEcCtD
Acebutolol—Weight increased—Temozolomide—melanoma	0.00106	0.00444	CcSEcCtD
Acebutolol—Pneumonia—Temozolomide—melanoma	0.00105	0.00438	CcSEcCtD
Acebutolol—Depression—Temozolomide—melanoma	0.00104	0.00434	CcSEcCtD
Acebutolol—Flushing—Bleomycin—melanoma	0.00103	0.0043	CcSEcCtD
Acebutolol—Body temperature increased—Vemurafenib—melanoma	0.00103	0.00429	CcSEcCtD
Acebutolol—Pharyngitis—Dactinomycin—melanoma	0.00103	0.00429	CcSEcCtD
Acebutolol—Chills—Bleomycin—melanoma	0.000996	0.00415	CcSEcCtD
Acebutolol—Cardiac failure congestive—Docetaxel—melanoma	0.000992	0.00414	CcSEcCtD
Acebutolol—Alopecia—Bleomycin—melanoma	0.000981	0.00409	CcSEcCtD
Acebutolol—Hallucination—Carmustine—melanoma	0.000964	0.00402	CcSEcCtD
Acebutolol—Hypoaesthesia—Carmustine—melanoma	0.000964	0.00402	CcSEcCtD
Acebutolol—Hot flush—Docetaxel—melanoma	0.000962	0.00401	CcSEcCtD
Acebutolol—Flushing—Dactinomycin—melanoma	0.00096	0.00401	CcSEcCtD
Acebutolol—Menopausal symptoms—Docetaxel—melanoma	0.000954	0.00398	CcSEcCtD
Acebutolol—Connective tissue disorder—Carmustine—melanoma	0.000952	0.00397	CcSEcCtD
Acebutolol—Visual disturbance—Docetaxel—melanoma	0.000949	0.00396	CcSEcCtD
Acebutolol—Asthenia—Vemurafenib—melanoma	0.000934	0.0039	CcSEcCtD
Acebutolol—Visual impairment—Carmustine—melanoma	0.000933	0.00389	CcSEcCtD
Acebutolol—Hypoaesthesia—Temozolomide—melanoma	0.000931	0.00389	CcSEcCtD
Acebutolol—Hallucination—Temozolomide—melanoma	0.000931	0.00389	CcSEcCtD
Acebutolol—Pharyngitis—Temozolomide—melanoma	0.000929	0.00388	CcSEcCtD
Acebutolol—Chills—Dactinomycin—melanoma	0.000929	0.00387	CcSEcCtD
Acebutolol—Cardiac failure—Docetaxel—melanoma	0.000922	0.00385	CcSEcCtD
Acebutolol—Pruritus—Vemurafenib—melanoma	0.000921	0.00384	CcSEcCtD
Acebutolol—Connective tissue disorder—Temozolomide—melanoma	0.00092	0.00384	CcSEcCtD
Acebutolol—Lethargy—Docetaxel—melanoma	0.000918	0.00383	CcSEcCtD
Acebutolol—Alopecia—Dactinomycin—melanoma	0.000914	0.00382	CcSEcCtD
Acebutolol—Visual impairment—Temozolomide—melanoma	0.000902	0.00376	CcSEcCtD
Acebutolol—Pain in extremity—Docetaxel—melanoma	0.0009	0.00375	CcSEcCtD
Acebutolol—Flushing—Carmustine—melanoma	0.000899	0.00375	CcSEcCtD
Acebutolol—Ill-defined disorder—Bleomycin—melanoma	0.000896	0.00374	CcSEcCtD
Acebutolol—Diarrhoea—Vemurafenib—melanoma	0.00089	0.00372	CcSEcCtD
Acebutolol—Tinnitus—Temozolomide—melanoma	0.000873	0.00364	CcSEcCtD
Acebutolol—Malaise—Bleomycin—melanoma	0.000871	0.00363	CcSEcCtD
Acebutolol—Flushing—Temozolomide—melanoma	0.000869	0.00362	CcSEcCtD
Acebutolol—Dizziness—Vemurafenib—melanoma	0.00086	0.00359	CcSEcCtD
Acebutolol—Alopecia—Carmustine—melanoma	0.000856	0.00357	CcSEcCtD
Acebutolol—Angiopathy—Temozolomide—melanoma	0.000849	0.00354	CcSEcCtD
Acebutolol—Mediastinal disorder—Temozolomide—melanoma	0.000844	0.00352	CcSEcCtD
Acebutolol—Cough—Bleomycin—melanoma	0.000843	0.00352	CcSEcCtD
Acebutolol—Chills—Temozolomide—melanoma	0.00084	0.0035	CcSEcCtD
Acebutolol—Ill-defined disorder—Dactinomycin—melanoma	0.000836	0.00349	CcSEcCtD
Acebutolol—Vomiting—Vemurafenib—melanoma	0.000827	0.00345	CcSEcCtD
Acebutolol—Alopecia—Temozolomide—melanoma	0.000827	0.00345	CcSEcCtD
Acebutolol—Chest pain—Bleomycin—melanoma	0.000822	0.00343	CcSEcCtD
Acebutolol—Myalgia—Bleomycin—melanoma	0.000822	0.00343	CcSEcCtD
Acebutolol—Orthostatic hypotension—Docetaxel—melanoma	0.000822	0.00343	CcSEcCtD
Acebutolol—Rash—Vemurafenib—melanoma	0.00082	0.00342	CcSEcCtD
Acebutolol—Dermatitis—Vemurafenib—melanoma	0.00082	0.00342	CcSEcCtD
Acebutolol—Back pain—Carmustine—melanoma	0.000816	0.0034	CcSEcCtD
Acebutolol—Headache—Vemurafenib—melanoma	0.000815	0.0034	CcSEcCtD
Acebutolol—Discomfort—Bleomycin—melanoma	0.000813	0.00339	CcSEcCtD
Acebutolol—Malaise—Dactinomycin—melanoma	0.000812	0.00339	CcSEcCtD
Acebutolol—Aspartate aminotransferase increased—Docetaxel—melanoma	0.00081	0.00338	CcSEcCtD
Acebutolol—Confusional state—Bleomycin—melanoma	0.000795	0.00332	CcSEcCtD
Acebutolol—Vision blurred—Carmustine—melanoma	0.000795	0.00332	CcSEcCtD
Acebutolol—Oedema—Bleomycin—melanoma	0.000788	0.00329	CcSEcCtD
Acebutolol—Back pain—Temozolomide—melanoma	0.000788	0.00329	CcSEcCtD
Acebutolol—Nausea—Vemurafenib—melanoma	0.000773	0.00323	CcSEcCtD
Acebutolol—Vision blurred—Temozolomide—melanoma	0.000768	0.0032	CcSEcCtD
Acebutolol—Myalgia—Dactinomycin—melanoma	0.000767	0.0032	CcSEcCtD
Acebutolol—Bronchospasm—Docetaxel—melanoma	0.000765	0.00319	CcSEcCtD
Acebutolol—Discomfort—Dactinomycin—melanoma	0.000758	0.00316	CcSEcCtD
Acebutolol—Ill-defined disorder—Temozolomide—melanoma	0.000756	0.00315	CcSEcCtD
Acebutolol—Anorexia—Bleomycin—melanoma	0.000751	0.00314	CcSEcCtD
Acebutolol—Hypotension—Bleomycin—melanoma	0.000737	0.00307	CcSEcCtD
Acebutolol—Oedema—Dactinomycin—melanoma	0.000735	0.00307	CcSEcCtD
Acebutolol—Malaise—Temozolomide—melanoma	0.000735	0.00307	CcSEcCtD
Acebutolol—Vertigo—Temozolomide—melanoma	0.000732	0.00305	CcSEcCtD
Acebutolol—Palpitations—Temozolomide—melanoma	0.00072	0.003	CcSEcCtD
Acebutolol—Musculoskeletal discomfort—Bleomycin—melanoma	0.000718	0.003	CcSEcCtD
Acebutolol—Chest pain—Carmustine—melanoma	0.000718	0.003	CcSEcCtD
Acebutolol—Myalgia—Carmustine—melanoma	0.000718	0.003	CcSEcCtD
Acebutolol—Anxiety—Carmustine—melanoma	0.000715	0.00299	CcSEcCtD
Acebutolol—Cough—Temozolomide—melanoma	0.000711	0.00297	CcSEcCtD
Acebutolol—Paraesthesia—Bleomycin—melanoma	0.000708	0.00295	CcSEcCtD
Acebutolol—Weight increased—Docetaxel—melanoma	0.000708	0.00295	CcSEcCtD
Acebutolol—Dyspnoea—Bleomycin—melanoma	0.000703	0.00293	CcSEcCtD
Acebutolol—Anorexia—Dactinomycin—melanoma	0.000701	0.00292	CcSEcCtD
Acebutolol—Pneumonia—Docetaxel—melanoma	0.000697	0.00291	CcSEcCtD
Acebutolol—Confusional state—Carmustine—melanoma	0.000694	0.0029	CcSEcCtD
Acebutolol—Myalgia—Temozolomide—melanoma	0.000694	0.00289	CcSEcCtD
Acebutolol—Arthralgia—Temozolomide—melanoma	0.000694	0.00289	CcSEcCtD
Acebutolol—Anxiety—Temozolomide—melanoma	0.000691	0.00288	CcSEcCtD
Acebutolol—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.000689	0.00287	CcSEcCtD
Acebutolol—Oedema—Carmustine—melanoma	0.000688	0.00287	CcSEcCtD
Acebutolol—Discomfort—Temozolomide—melanoma	0.000685	0.00286	CcSEcCtD
Acebutolol—Decreased appetite—Bleomycin—melanoma	0.000685	0.00286	CcSEcCtD
Acebutolol—Pain—Bleomycin—melanoma	0.000674	0.00281	CcSEcCtD
Acebutolol—Conjunctivitis—Docetaxel—melanoma	0.000674	0.00281	CcSEcCtD
Acebutolol—Confusional state—Temozolomide—melanoma	0.000671	0.0028	CcSEcCtD
Acebutolol—Musculoskeletal discomfort—Dactinomycin—melanoma	0.00067	0.0028	CcSEcCtD
Acebutolol—Oedema—Temozolomide—melanoma	0.000665	0.00277	CcSEcCtD
Acebutolol—Anorexia—Carmustine—melanoma	0.000656	0.00274	CcSEcCtD
Acebutolol—Nervous system disorder—Temozolomide—melanoma	0.000652	0.00272	CcSEcCtD
Acebutolol—Feeling abnormal—Bleomycin—melanoma	0.00065	0.00271	CcSEcCtD
Acebutolol—Agranulocytosis—Docetaxel—melanoma	0.000647	0.0027	CcSEcCtD
Acebutolol—Skin disorder—Temozolomide—melanoma	0.000646	0.0027	CcSEcCtD
Acebutolol—Hypotension—Carmustine—melanoma	0.000643	0.00268	CcSEcCtD
Acebutolol—Hyperhidrosis—Temozolomide—melanoma	0.000643	0.00268	CcSEcCtD
Acebutolol—Decreased appetite—Dactinomycin—melanoma	0.000639	0.00267	CcSEcCtD
Acebutolol—Fatigue—Dactinomycin—melanoma	0.000634	0.00265	CcSEcCtD
Acebutolol—Anorexia—Temozolomide—melanoma	0.000634	0.00265	CcSEcCtD
Acebutolol—Pain—Dactinomycin—melanoma	0.000629	0.00262	CcSEcCtD
Acebutolol—Musculoskeletal discomfort—Carmustine—melanoma	0.000627	0.00262	CcSEcCtD
Acebutolol—Urticaria—Bleomycin—melanoma	0.000626	0.00261	CcSEcCtD
Acebutolol—Rhinitis—Docetaxel—melanoma	0.000624	0.0026	CcSEcCtD
Acebutolol—Body temperature increased—Bleomycin—melanoma	0.000623	0.0026	CcSEcCtD
Acebutolol—Insomnia—Carmustine—melanoma	0.000622	0.0026	CcSEcCtD
Acebutolol—Hypoaesthesia—Docetaxel—melanoma	0.000619	0.00258	CcSEcCtD
Acebutolol—Paraesthesia—Carmustine—melanoma	0.000618	0.00258	CcSEcCtD
Acebutolol—Pharyngitis—Docetaxel—melanoma	0.000618	0.00258	CcSEcCtD
Acebutolol—Dyspnoea—Carmustine—melanoma	0.000614	0.00256	CcSEcCtD
Acebutolol—Somnolence—Carmustine—melanoma	0.000612	0.00255	CcSEcCtD
Acebutolol—Connective tissue disorder—Docetaxel—melanoma	0.000612	0.00255	CcSEcCtD
Acebutolol—Feeling abnormal—Dactinomycin—melanoma	0.000606	0.00253	CcSEcCtD
Acebutolol—Musculoskeletal discomfort—Temozolomide—melanoma	0.000606	0.00253	CcSEcCtD
Acebutolol—Insomnia—Temozolomide—melanoma	0.000601	0.00251	CcSEcCtD
Acebutolol—Gastrointestinal pain—Dactinomycin—melanoma	0.000601	0.00251	CcSEcCtD
Acebutolol—Visual impairment—Docetaxel—melanoma	0.0006	0.0025	CcSEcCtD
Acebutolol—Decreased appetite—Carmustine—melanoma	0.000598	0.0025	CcSEcCtD
Acebutolol—Paraesthesia—Temozolomide—melanoma	0.000597	0.00249	CcSEcCtD
Acebutolol—Gastrointestinal disorder—Carmustine—melanoma	0.000594	0.00248	CcSEcCtD
Acebutolol—Dyspnoea—Temozolomide—melanoma	0.000593	0.00247	CcSEcCtD
Acebutolol—Somnolence—Temozolomide—melanoma	0.000591	0.00247	CcSEcCtD
Acebutolol—Pain—Carmustine—melanoma	0.000588	0.00246	CcSEcCtD
Acebutolol—Constipation—Carmustine—melanoma	0.000588	0.00246	CcSEcCtD
Acebutolol—Dyspepsia—Temozolomide—melanoma	0.000585	0.00244	CcSEcCtD
Acebutolol—Abdominal pain—Dactinomycin—melanoma	0.000581	0.00243	CcSEcCtD
Acebutolol—Body temperature increased—Dactinomycin—melanoma	0.000581	0.00243	CcSEcCtD
Acebutolol—Decreased appetite—Temozolomide—melanoma	0.000578	0.00241	CcSEcCtD
Acebutolol—Flushing—Docetaxel—melanoma	0.000578	0.00241	CcSEcCtD
Acebutolol—Gastrointestinal disorder—Temozolomide—melanoma	0.000574	0.0024	CcSEcCtD
Acebutolol—Fatigue—Temozolomide—melanoma	0.000573	0.00239	CcSEcCtD
Acebutolol—Pain—Temozolomide—melanoma	0.000569	0.00237	CcSEcCtD
Acebutolol—Constipation—Temozolomide—melanoma	0.000569	0.00237	CcSEcCtD
Acebutolol—Feeling abnormal—Carmustine—melanoma	0.000567	0.00237	CcSEcCtD
Acebutolol—Asthenia—Bleomycin—melanoma	0.000566	0.00236	CcSEcCtD
Acebutolol—Angiopathy—Docetaxel—melanoma	0.000565	0.00236	CcSEcCtD
Acebutolol—Gastrointestinal pain—Carmustine—melanoma	0.000563	0.00235	CcSEcCtD
Acebutolol—Mediastinal disorder—Docetaxel—melanoma	0.000561	0.00234	CcSEcCtD
Acebutolol—Chills—Docetaxel—melanoma	0.000559	0.00233	CcSEcCtD
Acebutolol—Pruritus—Bleomycin—melanoma	0.000558	0.00233	CcSEcCtD
Acebutolol—Alopecia—Docetaxel—melanoma	0.00055	0.0023	CcSEcCtD
Acebutolol—Feeling abnormal—Temozolomide—melanoma	0.000548	0.00229	CcSEcCtD
Acebutolol—Body temperature increased—Carmustine—melanoma	0.000544	0.00227	CcSEcCtD
Acebutolol—Abdominal pain—Carmustine—melanoma	0.000544	0.00227	CcSEcCtD
Acebutolol—Gastrointestinal pain—Temozolomide—melanoma	0.000544	0.00227	CcSEcCtD
Acebutolol—Urticaria—Temozolomide—melanoma	0.000528	0.0022	CcSEcCtD
Acebutolol—Asthenia—Dactinomycin—melanoma	0.000528	0.0022	CcSEcCtD
Acebutolol—Body temperature increased—Temozolomide—melanoma	0.000526	0.00219	CcSEcCtD
Acebutolol—Abdominal pain—Temozolomide—melanoma	0.000526	0.00219	CcSEcCtD
Acebutolol—Back pain—Docetaxel—melanoma	0.000524	0.00219	CcSEcCtD
Acebutolol—Diarrhoea—Dactinomycin—melanoma	0.000503	0.0021	CcSEcCtD
Acebutolol—Vomiting—Bleomycin—melanoma	0.000501	0.00209	CcSEcCtD
Acebutolol—Rash—Bleomycin—melanoma	0.000497	0.00207	CcSEcCtD
Acebutolol—Dermatitis—Bleomycin—melanoma	0.000497	0.00207	CcSEcCtD
Acebutolol—Asthenia—Carmustine—melanoma	0.000494	0.00206	CcSEcCtD
Acebutolol—Syncope—Docetaxel—melanoma	0.000486	0.00203	CcSEcCtD
Acebutolol—Palpitations—Docetaxel—melanoma	0.000479	0.002	CcSEcCtD
Acebutolol—Asthenia—Temozolomide—melanoma	0.000477	0.00199	CcSEcCtD
Acebutolol—Loss of consciousness—Docetaxel—melanoma	0.000476	0.00199	CcSEcCtD
Acebutolol—Cough—Docetaxel—melanoma	0.000473	0.00197	CcSEcCtD
Acebutolol—Diarrhoea—Carmustine—melanoma	0.000471	0.00196	CcSEcCtD
Acebutolol—Pruritus—Temozolomide—melanoma	0.00047	0.00196	CcSEcCtD
Acebutolol—Nausea—Bleomycin—melanoma	0.000468	0.00195	CcSEcCtD
Acebutolol—Vomiting—Dactinomycin—melanoma	0.000467	0.00195	CcSEcCtD
Acebutolol—Rash—Dactinomycin—melanoma	0.000464	0.00193	CcSEcCtD
Acebutolol—Myalgia—Docetaxel—melanoma	0.000461	0.00192	CcSEcCtD
Acebutolol—Arthralgia—Docetaxel—melanoma	0.000461	0.00192	CcSEcCtD
Acebutolol—Chest pain—Docetaxel—melanoma	0.000461	0.00192	CcSEcCtD
Acebutolol—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.000458	0.00191	CcSEcCtD
Acebutolol—Dizziness—Carmustine—melanoma	0.000455	0.0019	CcSEcCtD
Acebutolol—Diarrhoea—Temozolomide—melanoma	0.000455	0.0019	CcSEcCtD
Acebutolol—Confusional state—Docetaxel—melanoma	0.000446	0.00186	CcSEcCtD
Acebutolol—Oedema—Docetaxel—melanoma	0.000442	0.00185	CcSEcCtD
Acebutolol—Dizziness—Temozolomide—melanoma	0.00044	0.00183	CcSEcCtD
Acebutolol—Vomiting—Carmustine—melanoma	0.000438	0.00183	CcSEcCtD
Acebutolol—Nausea—Dactinomycin—melanoma	0.000437	0.00182	CcSEcCtD
Acebutolol—Shock—Docetaxel—melanoma	0.000435	0.00182	CcSEcCtD
Acebutolol—Rash—Carmustine—melanoma	0.000434	0.00181	CcSEcCtD
Acebutolol—Nervous system disorder—Docetaxel—melanoma	0.000434	0.00181	CcSEcCtD
Acebutolol—Dermatitis—Carmustine—melanoma	0.000433	0.00181	CcSEcCtD
Acebutolol—Headache—Carmustine—melanoma	0.000431	0.0018	CcSEcCtD
Acebutolol—Skin disorder—Docetaxel—melanoma	0.00043	0.00179	CcSEcCtD
Acebutolol—Vomiting—Temozolomide—melanoma	0.000423	0.00176	CcSEcCtD
Acebutolol—Anorexia—Docetaxel—melanoma	0.000422	0.00176	CcSEcCtD
Acebutolol—Rash—Temozolomide—melanoma	0.000419	0.00175	CcSEcCtD
Acebutolol—Dermatitis—Temozolomide—melanoma	0.000419	0.00175	CcSEcCtD
Acebutolol—Headache—Temozolomide—melanoma	0.000417	0.00174	CcSEcCtD
Acebutolol—Hypotension—Docetaxel—melanoma	0.000413	0.00172	CcSEcCtD
Acebutolol—Nausea—Carmustine—melanoma	0.000409	0.00171	CcSEcCtD
Acebutolol—Musculoskeletal discomfort—Docetaxel—melanoma	0.000403	0.00168	CcSEcCtD
Acebutolol—Insomnia—Docetaxel—melanoma	0.0004	0.00167	CcSEcCtD
Acebutolol—Paraesthesia—Docetaxel—melanoma	0.000397	0.00166	CcSEcCtD
Acebutolol—Nausea—Temozolomide—melanoma	0.000395	0.00165	CcSEcCtD
Acebutolol—Dyspnoea—Docetaxel—melanoma	0.000394	0.00165	CcSEcCtD
Acebutolol—Somnolence—Docetaxel—melanoma	0.000393	0.00164	CcSEcCtD
Acebutolol—Dyspepsia—Docetaxel—melanoma	0.000389	0.00162	CcSEcCtD
Acebutolol—Decreased appetite—Docetaxel—melanoma	0.000384	0.0016	CcSEcCtD
Acebutolol—Gastrointestinal disorder—Docetaxel—melanoma	0.000382	0.00159	CcSEcCtD
Acebutolol—Fatigue—Docetaxel—melanoma	0.000381	0.00159	CcSEcCtD
Acebutolol—Pain—Docetaxel—melanoma	0.000378	0.00158	CcSEcCtD
Acebutolol—Constipation—Docetaxel—melanoma	0.000378	0.00158	CcSEcCtD
Acebutolol—Feeling abnormal—Docetaxel—melanoma	0.000364	0.00152	CcSEcCtD
Acebutolol—Gastrointestinal pain—Docetaxel—melanoma	0.000362	0.00151	CcSEcCtD
Acebutolol—Body temperature increased—Docetaxel—melanoma	0.00035	0.00146	CcSEcCtD
Acebutolol—Abdominal pain—Docetaxel—melanoma	0.00035	0.00146	CcSEcCtD
Acebutolol—Asthenia—Docetaxel—melanoma	0.000317	0.00132	CcSEcCtD
Acebutolol—Pruritus—Docetaxel—melanoma	0.000313	0.00131	CcSEcCtD
Acebutolol—Diarrhoea—Docetaxel—melanoma	0.000303	0.00126	CcSEcCtD
Acebutolol—Dizziness—Docetaxel—melanoma	0.000292	0.00122	CcSEcCtD
Acebutolol—Vomiting—Docetaxel—melanoma	0.000281	0.00117	CcSEcCtD
Acebutolol—Rash—Docetaxel—melanoma	0.000279	0.00116	CcSEcCtD
Acebutolol—Dermatitis—Docetaxel—melanoma	0.000279	0.00116	CcSEcCtD
Acebutolol—Headache—Docetaxel—melanoma	0.000277	0.00116	CcSEcCtD
Acebutolol—Nausea—Docetaxel—melanoma	0.000263	0.0011	CcSEcCtD
Acebutolol—ADRB2—Signaling Pathways—PTK2B—melanoma	2.84e-05	0.000388	CbGpPWpGaD
Acebutolol—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—melanoma	2.83e-05	0.000386	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—GAB2—melanoma	2.82e-05	0.000386	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—GNA11—melanoma	2.82e-05	0.000386	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—FLT1—melanoma	2.81e-05	0.000384	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—SDHD—melanoma	2.81e-05	0.000384	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—BSG—melanoma	2.81e-05	0.000384	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—CSPG4—melanoma	2.81e-05	0.000384	CbGpPWpGaD
Acebutolol—ADRB1—GPCR downstream signaling—PIK3CG—melanoma	2.79e-05	0.000381	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—GNAQ—melanoma	2.78e-05	0.000381	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—CD44—melanoma	2.78e-05	0.000381	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—GAB2—melanoma	2.76e-05	0.000378	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—GNA11—melanoma	2.76e-05	0.000378	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—FLT1—melanoma	2.75e-05	0.000376	CbGpPWpGaD
Acebutolol—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—melanoma	2.75e-05	0.000376	CbGpPWpGaD
Acebutolol—ADRB2—GPCR downstream signaling—PIK3CG—melanoma	2.72e-05	0.000372	CbGpPWpGaD
Acebutolol—SLC22A1—Neuronal System—HRAS—melanoma	2.72e-05	0.000372	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—GPAM—melanoma	2.72e-05	0.000372	CbGpPWpGaD
Acebutolol—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—melanoma	2.69e-05	0.000367	CbGpPWpGaD
Acebutolol—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—melanoma	2.69e-05	0.000367	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—CYP1B1—melanoma	2.67e-05	0.000365	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—HDAC2—melanoma	2.66e-05	0.000363	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—FOXO4—melanoma	2.66e-05	0.000363	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—CXCR4—melanoma	2.66e-05	0.000363	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—GNAQ—melanoma	2.63e-05	0.000359	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—HDAC2—melanoma	2.6e-05	0.000355	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—FOXO4—melanoma	2.6e-05	0.000355	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—CXCR4—melanoma	2.6e-05	0.000355	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—GNAQ—melanoma	2.57e-05	0.000351	CbGpPWpGaD
Acebutolol—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—melanoma	2.56e-05	0.00035	CbGpPWpGaD
Acebutolol—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—melanoma	2.54e-05	0.000347	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—PIK3CG—melanoma	2.53e-05	0.000346	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—PIK3CG—melanoma	2.47e-05	0.000338	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—SYK—melanoma	2.47e-05	0.000337	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—PLA2G6—melanoma	2.45e-05	0.000335	CbGpPWpGaD
Acebutolol—ADRB1—GPCR downstream signaling—PIK3CD—melanoma	2.45e-05	0.000335	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—ITGAV—melanoma	2.42e-05	0.000331	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—AKT3—melanoma	2.42e-05	0.000331	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—NGFR—melanoma	2.42e-05	0.000331	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—SYK—melanoma	2.41e-05	0.00033	CbGpPWpGaD
Acebutolol—ADRB2—GPCR downstream signaling—PIK3CD—melanoma	2.4e-05	0.000327	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—ITGAV—melanoma	2.37e-05	0.000324	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—NGFR—melanoma	2.37e-05	0.000324	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—AKT3—melanoma	2.37e-05	0.000324	CbGpPWpGaD
Acebutolol—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—melanoma	2.33e-05	0.000319	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—PLA2G6—melanoma	2.31e-05	0.000316	CbGpPWpGaD
Acebutolol—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—melanoma	2.26e-05	0.000308	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—SOCS1—melanoma	2.24e-05	0.000307	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—MAP2K1—melanoma	2.24e-05	0.000306	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—S100B—melanoma	2.24e-05	0.000306	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—PIK3CD—melanoma	2.22e-05	0.000304	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—VCAN—melanoma	2.2e-05	0.000301	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—ABCB1—melanoma	2.2e-05	0.0003	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—SOCS1—melanoma	2.19e-05	0.0003	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—MAP2K1—melanoma	2.19e-05	0.000299	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—S100B—melanoma	2.19e-05	0.000299	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—PIK3CD—melanoma	2.18e-05	0.000297	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—ERBB4—melanoma	2.14e-05	0.000292	CbGpPWpGaD
Acebutolol—ADRB1—GPCR downstream signaling—PIK3CB—melanoma	2.13e-05	0.000292	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—CDKN2B—melanoma	2.12e-05	0.00029	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—ERBB4—melanoma	2.09e-05	0.000286	CbGpPWpGaD
Acebutolol—ADRB2—GPCR downstream signaling—PIK3CB—melanoma	2.09e-05	0.000285	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—VCAN—melanoma	2.08e-05	0.000284	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—CDKN2B—melanoma	2.08e-05	0.000284	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—CD86—melanoma	2.05e-05	0.00028	CbGpPWpGaD
Acebutolol—ADRB1—GPCR downstream signaling—CXCL8—melanoma	2.05e-05	0.00028	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—EDN1—melanoma	2.04e-05	0.000278	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—PRKCA—melanoma	2.02e-05	0.000277	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—CD86—melanoma	2.01e-05	0.000274	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—ERCC2—melanoma	2.01e-05	0.000274	CbGpPWpGaD
Acebutolol—ADRB2—GPCR downstream signaling—CXCL8—melanoma	2.01e-05	0.000274	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—EDN1—melanoma	1.99e-05	0.000272	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—FGF1—melanoma	1.99e-05	0.000272	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—CSF2—melanoma	1.99e-05	0.000272	CbGpPWpGaD
Acebutolol—ADRB1—GPCR downstream signaling—IL2—melanoma	1.96e-05	0.000268	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—E2F1—melanoma	1.95e-05	0.000266	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—CSF2—melanoma	1.95e-05	0.000266	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—FGF1—melanoma	1.95e-05	0.000266	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—PIK3CB—melanoma	1.94e-05	0.000265	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—PDGFRA—melanoma	1.93e-05	0.000263	CbGpPWpGaD
Acebutolol—ADRB2—GPCR downstream signaling—IL2—melanoma	1.92e-05	0.000262	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—ITGB3—melanoma	1.91e-05	0.000261	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—PRKCA—melanoma	1.91e-05	0.000261	CbGpPWpGaD
Acebutolol—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—melanoma	1.91e-05	0.00026	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—E2F1—melanoma	1.9e-05	0.00026	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—PIK3CB—melanoma	1.9e-05	0.000259	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—PDGFRA—melanoma	1.88e-05	0.000258	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—SPP1—melanoma	1.87e-05	0.000256	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—PRKCA—melanoma	1.87e-05	0.000255	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—ITGB3—melanoma	1.87e-05	0.000255	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—MAP2K2—melanoma	1.86e-05	0.000255	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—CXCL8—melanoma	1.86e-05	0.000255	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—CYP17A1—melanoma	1.86e-05	0.000254	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—SPP1—melanoma	1.83e-05	0.00025	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—MAP2K2—melanoma	1.82e-05	0.000249	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—CXCL8—melanoma	1.82e-05	0.000249	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—IL2—melanoma	1.78e-05	0.000243	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—TERT—melanoma	1.77e-05	0.000242	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—RAC1—melanoma	1.77e-05	0.000242	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—GNA11—melanoma	1.76e-05	0.00024	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—CYP17A1—melanoma	1.75e-05	0.000239	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—IL2—melanoma	1.74e-05	0.000238	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—TERT—melanoma	1.73e-05	0.000237	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—RAC1—melanoma	1.73e-05	0.000236	CbGpPWpGaD
Acebutolol—ABCB1—Transmembrane transport of small molecules—ALB—melanoma	1.72e-05	0.000235	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—FASN—melanoma	1.72e-05	0.000235	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—HIF1A—melanoma	1.7e-05	0.000232	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—SLC5A5—melanoma	1.69e-05	0.000231	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—HIF1A—melanoma	1.66e-05	0.000227	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—GNA11—melanoma	1.65e-05	0.000226	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—GNAQ—melanoma	1.63e-05	0.000223	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—CD44—melanoma	1.63e-05	0.000223	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—KDR—melanoma	1.62e-05	0.000222	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—FASN—melanoma	1.62e-05	0.000221	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—SLC5A5—melanoma	1.59e-05	0.000218	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—KDR—melanoma	1.59e-05	0.000217	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—PIK3CG—melanoma	1.58e-05	0.000217	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—CYP1B1—melanoma	1.56e-05	0.000214	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—FN1—melanoma	1.56e-05	0.000213	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—CD44—melanoma	1.54e-05	0.00021	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—GNAQ—melanoma	1.54e-05	0.00021	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—PPARG—melanoma	1.53e-05	0.000209	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—NOTCH1—melanoma	1.53e-05	0.000209	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—FN1—melanoma	1.53e-05	0.000209	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—CD80—melanoma	1.5e-05	0.000205	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—NOTCH1—melanoma	1.49e-05	0.000204	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—PIK3CG—melanoma	1.49e-05	0.000204	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—APC—melanoma	1.49e-05	0.000204	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—KIT—melanoma	1.49e-05	0.000204	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—NRAS—melanoma	1.49e-05	0.000204	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—EGF—melanoma	1.48e-05	0.000202	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—CYP1B1—melanoma	1.47e-05	0.000202	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—CD80—melanoma	1.46e-05	0.0002	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—PIK3CG—melanoma	1.46e-05	0.0002	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—APC—melanoma	1.46e-05	0.0002	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—KIT—melanoma	1.46e-05	0.0002	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—NRAS—melanoma	1.46e-05	0.0002	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—EGF—melanoma	1.44e-05	0.000197	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—MAPK3—melanoma	1.43e-05	0.000196	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—BRAF—melanoma	1.4e-05	0.000192	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—MAPK3—melanoma	1.4e-05	0.000191	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—PIK3CD—melanoma	1.39e-05	0.00019	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—ALB—melanoma	1.38e-05	0.000188	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—BRAF—melanoma	1.37e-05	0.000188	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—IGF1—melanoma	1.37e-05	0.000187	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—MAPK1—melanoma	1.36e-05	0.000186	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—EGFR—melanoma	1.36e-05	0.000186	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—IGF1—melanoma	1.34e-05	0.000183	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—MAPK1—melanoma	1.33e-05	0.000182	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—EGFR—melanoma	1.33e-05	0.000182	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—MAP2K1—melanoma	1.32e-05	0.000181	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—PIK3CD—melanoma	1.31e-05	0.00018	CbGpPWpGaD
Acebutolol—ADRB1—GPCR downstream signaling—PIK3CA—melanoma	1.3e-05	0.000178	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—MAP2K1—melanoma	1.29e-05	0.000177	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—KRAS—melanoma	1.29e-05	0.000176	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—PIK3CD—melanoma	1.28e-05	0.000176	CbGpPWpGaD
Acebutolol—ADRB2—GPCR downstream signaling—PIK3CA—melanoma	1.27e-05	0.000174	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—KRAS—melanoma	1.26e-05	0.000172	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—FGF2—melanoma	1.26e-05	0.000172	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—FGF2—melanoma	1.23e-05	0.000168	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—PIK3CB—melanoma	1.21e-05	0.000166	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—ABCB1—melanoma	1.21e-05	0.000166	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—PTGS2—melanoma	1.2e-05	0.000164	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—PRKCA—melanoma	1.19e-05	0.000162	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—PIK3CA—melanoma	1.18e-05	0.000161	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—MDM2—melanoma	1.18e-05	0.000161	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—ERCC2—melanoma	1.18e-05	0.000161	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—ERBB2—melanoma	1.16e-05	0.000159	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—PIK3CA—melanoma	1.16e-05	0.000158	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—MDM2—melanoma	1.15e-05	0.000157	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—PIK3CB—melanoma	1.14e-05	0.000156	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—ERBB2—melanoma	1.13e-05	0.000155	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—PIK3CB—melanoma	1.12e-05	0.000153	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—PRKCA—melanoma	1.12e-05	0.000153	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—ERCC2—melanoma	1.11e-05	0.000151	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—CXCL8—melanoma	1.1e-05	0.00015	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—HRAS—melanoma	1.09e-05	0.000149	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—CXCL8—melanoma	1.08e-05	0.000147	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—CDKN1B—melanoma	1.07e-05	0.000147	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—HRAS—melanoma	1.07e-05	0.000146	CbGpPWpGaD
Acebutolol—ADRB1—GPCR downstream signaling—AKT1—melanoma	1.06e-05	0.000145	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—CASP3—melanoma	1.05e-05	0.000144	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—IL2—melanoma	1.05e-05	0.000144	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—CDKN1B—melanoma	1.05e-05	0.000144	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—PTEN—melanoma	1.05e-05	0.000143	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—IL6—melanoma	1.05e-05	0.000143	CbGpPWpGaD
Acebutolol—ADRB2—GPCR downstream signaling—AKT1—melanoma	1.04e-05	0.000142	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—CASP3—melanoma	1.03e-05	0.000141	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—IL2—melanoma	1.03e-05	0.000141	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—CCND1—melanoma	1.02e-05	0.00014	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—IL6—melanoma	1.02e-05	0.00014	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—CTNNB1—melanoma	1.02e-05	0.000139	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—CCND1—melanoma	1e-05	0.000137	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—MMP9—melanoma	9.95e-06	0.000136	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—CTNNB1—melanoma	9.93e-06	0.000136	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—CDKN1A—melanoma	9.92e-06	0.000136	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—PTEN—melanoma	9.89e-06	0.000135	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—NFKB1—melanoma	9.85e-06	0.000135	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—MMP9—melanoma	9.73e-06	0.000133	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—CDKN1A—melanoma	9.7e-06	0.000133	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—PTEN—melanoma	9.68e-06	0.000132	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—AKT1—melanoma	9.65e-06	0.000132	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—NFKB1—melanoma	9.63e-06	0.000132	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—AKT1—melanoma	9.44e-06	0.000129	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—PIK3CG—melanoma	9.29e-06	0.000127	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—PPARG—melanoma	8.97e-06	0.000123	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—VEGFA—melanoma	8.94e-06	0.000122	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—STAT3—melanoma	8.85e-06	0.000121	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—NRAS—melanoma	8.83e-06	0.000121	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—PIK3CG—melanoma	8.75e-06	0.00012	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—VEGFA—melanoma	8.74e-06	0.000119	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—STAT3—melanoma	8.65e-06	0.000118	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—NRAS—melanoma	8.63e-06	0.000118	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—MAPK3—melanoma	8.45e-06	0.000116	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—PPARG—melanoma	8.45e-06	0.000115	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—MAPK3—melanoma	8.27e-06	0.000113	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—MYC—melanoma	8.22e-06	0.000112	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—PIK3CD—melanoma	8.17e-06	0.000112	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—ALB—melanoma	8.06e-06	0.00011	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—MAPK1—melanoma	8.04e-06	0.00011	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—MYC—melanoma	8.04e-06	0.00011	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—EGFR—melanoma	8.04e-06	0.00011	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—MAPK1—melanoma	7.87e-06	0.000108	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—EGFR—melanoma	7.87e-06	0.000108	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—PIK3CD—melanoma	7.7e-06	0.000105	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—KRAS—melanoma	7.6e-06	0.000104	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—ALB—melanoma	7.6e-06	0.000104	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—KRAS—melanoma	7.43e-06	0.000102	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—PIK3CA—melanoma	7.4e-06	0.000101	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—PIK3CB—melanoma	7.12e-06	9.73e-05	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—PTGS2—melanoma	7.05e-06	9.64e-05	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—PIK3CA—melanoma	6.98e-06	9.54e-05	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—PIK3CA—melanoma	6.83e-06	9.33e-05	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—TP53—melanoma	6.75e-06	9.23e-05	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—PIK3CB—melanoma	6.71e-06	9.17e-05	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—PTGS2—melanoma	6.65e-06	9.08e-05	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—TP53—melanoma	6.6e-06	9.03e-05	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—HRAS—melanoma	6.46e-06	8.82e-05	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—HRAS—melanoma	6.32e-06	8.63e-05	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—IL6—melanoma	6.18e-06	8.45e-05	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—PTEN—melanoma	6.15e-06	8.41e-05	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—AKT1—melanoma	6.05e-06	8.27e-05	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—IL6—melanoma	6.05e-06	8.26e-05	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—PTEN—melanoma	5.8e-06	7.92e-05	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—AKT1—melanoma	5.7e-06	7.79e-05	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—AKT1—melanoma	5.58e-06	7.62e-05	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—PIK3CA—melanoma	4.34e-06	5.93e-05	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—PIK3CA—melanoma	4.09e-06	5.59e-05	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—AKT1—melanoma	3.54e-06	4.84e-05	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—AKT1—melanoma	3.34e-06	4.57e-05	CbGpPWpGaD
